Europe Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)
Market Introduction
Diltiazem is a benzothiazepine derivative that acts as an antihypertensive and vasodilator. Diltiazem is an antihypertensive and vasodilator that lowers blood pressure by relaxing the vascular muscle. This is due to the long-term therapeutic effects of decreasing blood pressure since it lowers the risk of fatal and non-fatal cardiovascular events, such as strokes and myocardial infarction. According to in vitro binding experiments, diltiazem is 70%-80% bound to plasma proteins. At clinically relevant concentrations, around 40% of the medication is thought to attach to alpha-1-glycoprotein, whereas about 30% of the drug is thought to bind to albumin.
Get more information on this report :
Market Overview and Dynamics
The Europe diltiazem market is expected to reach US$ 207.38 million by 2028 from US$ 95.08 million in 2021; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028. Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases, and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, side effects of diltiazem on consumption are likely to negatively impact the growth of the market in the coming years.
Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to Cardiovascular dieseses (CVDs) such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in Europe. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market.
The European market is severely hit due to the exponential increase of COVID-19 cases in the region. The rising rate of COVID-19 is resulting in increased stress on the region's healthcare system, increasing the need for diagnostic tests in its healthcare system, encouraging the expansion of the sector in this region. Hypertension has been recorded in various cases and retrospective groups as a possible risk factor for the frequency and severity of COVID-19. Since the SARS-CoV-2's high infectivity rates, a possible interaction between COVID-19 and hypertension is worrisome. Diltiazem may be helpful to treat hypertension associated with COVID-19. Overall, diltiazem plays dual effects on hypertension-linked COVID-19 treatment by lowering high blood pressure and restraining NF-kb signaling pathway-related inflammation. The region witnessed some shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end users lost their business due to the temporarily shutting down of industries in various regions. However, the diltiazem market witnessed growth during the pandemic as it is anticipated to inhibit viral growth and related hypertension.
Key Market Segments
Based on product, the Europe diltiazem market is segmented into capsules, injection, and tablets. In 2021, the tablets segment held the largest share of the market. However, the capsules segment is expected to grow at the fastest CAGR from 2021 to 2028.
Based on application, the Europe diltiazem market was segmented into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market. The angina segment is expected to grow at the fastest CAGR during the coming years.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe diltiazem market are the National Health Service (NHS), Organization for Economic Co-operation and Development (OECD), and World Health Organization (WHO), among others.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe diltiazem market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe diltiazem market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe diltiazem market.
EUROPE DILTIAZEM MARKET SEGMENTATION
By Product Type
- Tablet
- Capsules
- Injection
By Application
- Hypertension
- Angina
- Others
By Country
- Italy
- Germany
- Spain
- France
- UK
- Rest of Europe
Company Profiles
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Diltiazem Market – By Product Type
1.3.2 Europe Diltiazem Market – By Application
1.3.3 Europe Diltiazem Market – By Country
2. Europe Diltiazem Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Diltiazem Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.3 Experts Opinion
5. Diltiazem Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Cardiovascular Disease Incidence
5.1.2 Increasing Elderly Population
5.2 Market Restraints
5.2.1 Side Effects of Diltiazem
5.3 Future Trends
5.3.1 Recent Developments in Market
5.4 Impact Analysis
6. Diltiazem Market – Europe Analysis
6.1 Europe Diltiazem Market Revenue Forecast and Analysis
7. Diltiazem Market Analysis and forecasts to 2028 – Product Type
7.1 Overview
7.2 Diltiazem Market Share by Product Type 2021 & 2028 (%)
7.3 Capsules
7.3.1 Overview
7.3.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Injection
7.4.1 Overview
7.4.2 Injection Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Tablets
7.5.1 Overview
7.5.2 Tablet Market Revenue and Forecast to 2028 (US$ Mn)
8. Diltiazem Market Analysis and Forecasts To 2028 – Application
8.1 Overview
8.2 Diltiazem Market Share by Application 2021 & 2028 (%)
8.3 Angina
8.3.1 Overview
8.3.2 Angina Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Hypertension
8.4.1 Overview
8.4.2 Hypertension Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Others
8.5.1 Overview
8.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Diltiazem Market – Europe Analysis
9.1 Europe: Diltiazem Market
9.1.1 Europe: Diltiazem Market, by Country, 2021 & 2028 (%)
9.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 UK: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 UK: Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Germany: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Germany: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.3 France: Diltiazem Market - Revenue and Forecasts to 2028 (USD Million)
9.1.1.3.1 France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 France: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 France: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.4 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Spain: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Spain: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Italy: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Italy: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Europe: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Diltiazem Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Diltiazem Market–Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies In The Diltiazem Market
12. Company Profiles
12.1 Bausch Health Companies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Teva Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MYLAN N.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sandoz (Novartis AG)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sun Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Hikma Pharmaceuticals PLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Zydus Cadila
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Glenmark
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UK Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. UK Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. France Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 6. France Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Spain Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Spain Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Italy Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Italy Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of Europe Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Europe Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Glossary of Terms, Diltiazem Market
LIST OF FIGURES
Figure 1. Diltiazem Market Segmentation
Figure 2. Diltiazem Market Segmentation, By Country
Figure 3. Europe Diltiazem Market Overview
Figure 4. Tablets Held the Largest Share of the Product Segment in Diltiazem Market
Figure 5. Europe Diltiazem Market – Leading Country Markets (US$ Million)
Figure 6. Europe and PEST Analysis
Figure 7. Diltiazem Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Diltiazem Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Diltiazem Market Share by Product Type 2021 & 2028 (%)
Figure 10. Capsules Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Injection Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Tablet Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Diltiazem Market Share by Application 2021 & 2028 (%)
Figure 14. Angina Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Hypertension Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe: Diltiazem Market, by Key Country – Revenue (2021) (USD Million)
Figure 18. Europe: Diltiazem Market, by Country, 2021 & 2028 (%)
Figure 19. UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Impact of COVID-19 Pandemic in European Country Markets
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe diltiazem market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe diltiazem market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.